MSWM
BIIB icon

Mowery & Schoenfeld Wealth Management’s Biogen BIIB Stock Holding History

Mowery & Schoenfeld Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$1.76K – 375
2025
Q4 		$1.76K Buy
+10
New +$1.63K ﹤0.01% 402

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mowery & Schoenfeld Wealth Management's BIIB Position: Q1 2026 in Review

Mowery & Schoenfeld Wealth Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 10 shares — an estimated $1.76K sold.

Mowery & Schoenfeld Wealth Management first reported a position in BIIB in Q4 2025 and held it in 1 quarter. The position peaked at $1.76K in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Mowery & Schoenfeld Wealth Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Mowery & Schoenfeld Wealth Management sold 10 Biogen shares in Q1 2026, an estimated $1.76K.
  • Mowery & Schoenfeld Wealth Management first reported a position in Biogen in Q4 2025 and held it in 1 quarter.
  • Mowery & Schoenfeld Wealth Management's Biogen position peaked at $1.76K in Q4 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.